Buy Rating Affirmed for Esperion Due to Bempedoic Acid’s Clinical Efficacy in Recent Trials
Esperion (ESPR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from ...